vicc

For more news from the Vanderbilt-Ingram Cancer Center, visit their website »

January 31, 2013

Vanderbilt, GE unite to study colon tumor development

Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop.

By Bill Snyder

January 31, 2013

For Cancer Center’s Joyce, volunteering comes naturally

Nearly every week since 1988, cancer patients and families visiting Vanderbilt University Medical Center have been able to count on a comforting routine — at least one morning per week they are greeted by the same smiling volunteer who dispenses a dose of friendship along with coffee, snacks and advice about how to navigate the sprawling Medical Center campus.

By VUMC News and Communications

January 30, 2013

Long-term effects of prostate therapies tracked

A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment.

By VUMC News and Communications

December 7, 2012

Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers

Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators.